Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut microbiota and immunometabolism in obesity

  • Torres Mayo, Alba
  • Liébana García, Rebeca
  • Olivares, Marta
  • Pellón, Aize
  • Anguita, Juan
  • Sanz Herranz, Yolanda
The gut microbiota plays a central role in modulating both immunity and metabolism. Obesity-associated microbiota configuration is a critical driver of persistent inflammatory activation and immune dysfunction, ultimately leading to chronic metabolic disorders. Immunometabolism examines how metabolic demands shape immune cell function and how immune responses influence cellular metabolism. Emerging research on how the gut microbiota contribute to immune cell metabolic processes and the resulting health outcomes is deepening our understanding of the mechanisms underlying obesity and metabolic diseases. In this review, we summarize how intracellular metabolic pathways and master regulators, such as mTOR and AMPK, orchestrate immune cell function and how their dysregulation contributes to obesity-associated immune and metabolic dysfunction. We also discuss how gut microbiota influences the immunometabolism of different myeloid and lymphoid cell subsets and intestinal epithelial cells. Finally, we review the role of microbially produced metabolites, including short-chain fatty acids, lactate, succinate, bile acids, and amino acids, in reprogramming immune cell metabolism. We also discuss whether modulating gut microbiota function to regulate immunometabolic pathways could help restore immune homeostasis and reduce obesity-related complications., This study has been funded by the Spanish Ministry of Science, Innovation and Universities (MCIU; grant PID2023-150693OB-I00 to YS, PID2024-155763OB-I00 to JA), and the “Severo Ochoa” grant of the National Agency for Research (AEI)- MCIU (Ref. CEX2021-001189-S to IATA-CSIC, CEX2021-001136-S to CIC bioGUNE). The predoctoral contract to A. T-M from MCIU is acknowledged. AP is supported by an MSCA Postdoctoral Fellowship (award number 101150747)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S and CEX2021-001136-S)., Peer reviewed